Development and validation of a new HPLC method for simultaneous determination of esomeprazole, venlafaxine HCl and fenofibrate

dc.contributor.author	Kumar, K. S.
dc.contributor.author	Samnani, P. B.
dc.date.accessioned	2017-09-07T10:13:56Z
dc.date.available	2017-09-07T10:13:56Z
dc.date.issued	2014
dc.identifier.issn	0974-4290
dc.identifier.issn	2455-9555 (e-ISSN)
dc.identifier.uri	http://27.109.7.66:8080/xmlui/handle/123456789/442
dc.description	International Journal of ChemTech Research CODEN (USA): IJCRGG ISSN: 0974-4290 Vol.6, No.1, pp 838-844, Jan-March 2014	en_US
dc.description.abstract	A new gradient reversed-phase liquid chromatographic method was developed for the simultaneous determination of Esomeprazole, Venlafaxine HCl and Fenofibrate in water. The chromatographic separation of these analytes was done by C18 column using a mixture of acetonitrile: buffer (0.3 % formic acid) in the ratio 25:75 (v/v) as mobile phase A and in the ratio 30:70 (v/v) as mobile phase B at a wavelength of 230 nm. The Linearity of the method was found to be in the concentration range of 10.37 – 518.40 mg / L for three drugs with correlation coefficient greater than 0.999.	en_US
dc.language.iso	en	en_US
dc.publisher	SPHINX Knowledge House	en_US
dc.subject	Esomeprazole	en_US
dc.subject	Venlafaxine HCl	en_US
dc.subject	Fenofibrate	en_US
dc.subject	HPLC	en_US
dc.subject	Gradient	en_US
dc.title	Development and validation of a new HPLC method for simultaneous determination of esomeprazole, venlafaxine HCl and fenofibrate	en_US
dc.type	Article	en_US